Expression and Significance of Cytokeratin 7, a Squamocolumnar Junction Marker, in Head and Neck Squamous Cell Carcinoma
Head and Neck Pathology · 2018-12 · 12 (4) · 448-454
DOI: 10.1007/s12105-017-0874-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head and Neck Pathology, online erschienen am 12.12.2017. Verfasst von Mitra Mehrad und 3 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt University Medical Center, Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, C-3321A Medical Center North…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The favorable features of high-risk human papillomavirus (HPV) in the head and neck are limited to those harboring transcriptionally-active HPV, which occur predominantly in the oropharynx (OP). Factors rendering the OP susceptible to HPV oncogenesis are largely unexplored. The role of cytokeratin 7 (CK7) in predisposition to HPV and cancer in the cervix has been evaluated. However, its significance in the H&N is unknown. CK7 immunohistochemistry was performed on a tissue microarray cohort of OP and non-oropharyngeal (NOP) squamous cell carcinomas (SCC) with known clinical follow-up and HPV E6/7 mRNA status. Expression was graded based on the distribution (1 ≤ 33%, 2 = 33-66%, 3 ≥ 66%) and intensity (1 = weak, 2 = strong) with combined score of ≥ 2 considered positive. Survival analysis was performed. Seventy-four NOPSCCs and 204 OPSCCs were studied. HPV was positive in 2.7% of NOPSCCs and 70.9% of OPSCCs. CK7 was positive in 23.0% of OPSCCs and 14.8% of NOPSCCs (p = 0.2), and in 24.1% of HPV positive versus 17.2% of negative patients (p = 0.2). There was no correlation with age, race, gender, HPV status, histologic type, tumor subsite, treatment, stage, or co-morbidities, and CK7 expression was not significantly associated with overall or disease specific survival. In our series, CK7 is positive in ~ 25% of H&N SCCs, although usually only focally. While CK7 has been suspected to be overexpressed selectively in HPV-related OPSCCs due to their origination from tonsillar crypt epithelium, we did not find any significant difference by anatomic H&N subsite, nor by HPV status, for its expression and found no association with patient survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vanderbilt University Medical Center, Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, C-3321A Medical Center North, Nashville, TN, 37232, USA. mitra.mehrad@vanderbilt.edu.
- Vanderbilt University Medical Center, Biostatistics, Nashville, TN, USA.
- Vanderbilt University Medical Center, Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, C-3321A Medical Center North, Nashville, TN, 37232, USA.
- Vanderbilt University Medical Center, Otolaryngology, Nashville, TN, USA.
Zitieren
APA
Mehrad, M., Dupont, W. D., Plummer, W. D., & Lewis, J. S. (2018). Expression and Significance of Cytokeratin 7, a Squamocolumnar Junction Marker, in Head and Neck Squamous Cell Carcinoma. Head and Neck Pathology, 12(4), 448-454. https://doi.org/10.1007/s12105-017-0874-2
Vancouver
Mehrad M, Dupont WD, Plummer WD, Lewis JS. Expression and Significance of Cytokeratin 7, a Squamocolumnar Junction Marker, in Head and Neck Squamous Cell Carcinoma. Head and Neck Pathology. 2018;12(4):448-454. doi:10.1007/s12105-017-0874-2
BibTeX
@article{Mehrad2018,
author = {Mehrad, Mitra and Dupont, William D and Plummer, W Dale and Lewis, James S},
title = {Expression and Significance of Cytokeratin 7, a Squamocolumnar Junction Marker, in Head and Neck Squamous Cell Carcinoma},
journal = {Head and Neck Pathology},
year = {2018},
volume = {12},
number = {4},
pages = {448--454},
doi = {10.1007/s12105-017-0874-2}
}
EUVIMED